Advanced Cell Technology Announces Webcast of Corporate Presentation at Annual Shareholders’ Meeting Today

  Advanced Cell Technology Announces Webcast of Corporate Presentation at   Annual Shareholders’ Meeting Today     Webcast to Commence at 9:15 a.m. PDT After Formal Portion of Meeting has                                   Concluded  Business Wire  MARLBOROUGH, Mass. -- April 26, 2012  Advanced Cell Technology, Inc. (“ACT”;OTCBB: ACTC), a leader in the field of regenerative medicine, announced that it will webcast today’s corporate presentation at 9:15 a.m. PDT, after the formal portion of its Annual Shareholders’ Meeting has concluded. Prior to the webcast, proxy voting will be completed and the results announced to the shareholders in attendance. The meeting is open to shareholders of record as of March 1, 2012. After the corporate presentation, the Company will address questions from shareholders in attendance, as well as electronically via the webcast.  The webcast will be available live and via replay at: http://us.meeting-stream.com/advancedcelltechnology042612  The Presentation schedule is as follows:    *Corporate Overview- Gary Rabin, Chairman and CEO   *Pre-clinical Programs Summary- Robert Lanza, M.D., CSO   *RPE Clinical Program Update and FDA planning for Phase 2- Ed Mickunas, VP     of Regulatory and Clinical Affairs   *Financial Overview- Kathy Singh, Controller   *Strategic and Corporate Opportunities- Matt Vincent, Ph.D., Director of     Business Development  About Advanced Cell Technology, Inc.  Advanced Cell Technology, Inc., is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visitwww.advancedcell.com.  Forward-Looking Statements  Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words “will,” “believes,” “plans,” “anticipates,” “expects,” “estimates,” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company’s periodic reports, including the report on Form 10-K for the year ended December 31, 2011. Forward-looking statements are based on the beliefs, opinions, and expectations of the company’s management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. Forward-looking statements are based on the beliefs, opinions, and expectations of the company’s management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. There can be no assurance that the Company’s clinical trials will be successful.  Contact:  Investors: CEOcast, Inc. James Young, 212-732-4300 or Press: ACT Corporate Communications Bill Douglass, 646-450-3615 or Russo Partners Martina Schwarzkopf, Ph.D., 212-845-4292 or Business Development: Advanced Cell Technology Matthew Vincent, Ph.D., 508-756-1212 x324 mvincent@advancedcell.com  
Press spacebar to pause and continue. Press esc to stop.